Cardiovascular diagnostic biomarkers - The past, present and future

Circulation Journal

Volumn 73, Issue 5, 2009, Pages 806-809

  Suzuki, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aorta; Biomarkers; Diagnosis; Dissection

Indexed keywords

BIOLOGICAL MARKER; CALPONIN; CREATINE KINASE BB; LOW DENSITY LIPOPROTEIN; MYOSIN;

AORTA DISSECTION; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HEART FAILURE; HUMAN; ISCHEMIA; MASS SPECTROMETRY; PERCUTANEOUS CORONARY INTERVENTION; REVIEW;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LIPOPROTEINS, LDL; MASS SPECTROMETRY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS;

EID: 65649116889     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1157     Document Type: Review

References (29)

1. Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res 2001; 51: 489-494. (Pubitemid 32718597)
2. th edition): Edited by EF Bernstein (1993). Cardiovasc Res 1995; 29: 583-584.
3. st ed. USA; 1992.
4. Suzuki T, Katoh H, Nagai R. Biochemical diagnosis of aortic dissection: From bench to bedside. Jpn Heart J 1999; 40: 527-534.
5. Katoh H, Suzuki T, Hiroi Y, Ohtaki E, Suzuki S, Yazaki Y, et al. Diagnosis of aortic dissection by immunoassay for circulating smooth muscle myosin. Lancet 1995; 345: 191-192.
6. Katoh H, Suzuki T, Yokomori K, Suzuki S, Ootaki E, Watanabe M, et al. A novel immunoassay of smooth muscle myosin heavy chain in serum. J Immunol Methods 1995; 185: 57-63.
7. Suzuki T, Katoh H, Watanabe M, Kurabayashi M, Hiramori K, Hori S, et al. A novel biochemical method for aortic dissection: The results of a prospective study using an immunoassay of smooth muscle myosin heavy chain. Circulation 1996; 93: 1244-1249. (Pubitemid 26087028)
8. Suzuki T, Katoh H, Tsuchio Y, Hasegawa A, Kurabayashi M, Ohira A, et al. Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection: The smooth muscle myosin heavy chain study. Ann Intern Med 2000; 133: 537-541.
9. Suzuki T, Katoh H, Kurabayashi M, Yazaki Y, Nagai R. Biochemical diagnosis of aortic dissection by raised concentrations of creatine kinase BB-isozyme. Lancet 1997; 350: 784-785. (Pubitemid 27387213)
10. Suzuki T, Distante A, Zizza A, Trimarchi S, Villani M, Salerno Uriarte JA, et al. Preliminary experience with the smooth muscle troponin-like protein, calponin, as a novel biomarker for diagnosing acute aortic dissection. Eur Heart J 2008; 29: 1439-1445.
11. Hata M, Sezai A, Niino T, Yoda M, Wakui S, Unosawa S, et al. Prognosis for patients with type B acute aortic dissection: Risk analysis of early death and requirement for elective surgery. Circ J 2007; 71: 1279-1282. (Pubitemid 47201779)
12. Sakakura K, Kubo N, Ako J, Ikeda N, Funayama H, Hirahara T, et al. Determinants of in-hospital death and rupture in patients with a Stanford B aortic dissection. Circ J 2007; 71: 1521-1524. (Pubitemid 47529649)
13. Takeshita S, Sakamoto S, Kitada S, Akutsu K, Hashimoto H. Angiotensin-converting enzyme inhibitors reduce long-term aortic events in patients with acute type B aortic dissection. Circ J 2008; 72: 1758-1761.
14. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): New insights into an old disease. JAMA 2000; 283: 897-903. (Pubitemid 30102130)
15. Mehta RH, Suzuki T, Hagan PG, Bossone E, Gilon D, Llovet A, et al. Predicting death in patients with acute type A aortic dissection. Circulation 2002; 105: 200-206. (Pubitemid 34084319)
16. Suzuki T, Mehta RH, Ince H, Nagai R, Sakomura Y, Weber F, et al. Clinical profiles and outcomes of acute type B aortic dissection in the current era: Lessons from the International Registry of Aortic Dissection (IRAD). Circulation 2003; 108: II-312-II-317. (Pubitemid 37099974)
17. Tsai TT, Evangelista A, Nienaber CA, Myrmel T, Meinhardt G, Cooper JV, et al. Partial thrombosis of the false limen in patients with acute type B aortic dissection. N Engl J Med 2007; 357: 349-359. (Pubitemid 47124135)
18. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, et al. Circulating oxidized low density lipoprotein levels: A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 2000; 20: 2243-2247.
19. Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 2002; 35: 347-353. (Pubitemid 35247942)
20. Amaki T, Suzuki T, Nakamura F, Hayashi D, Imai Y, Morita H, et al. Circulating malondialdehyde modified LDL is a biochemical risk marker for coronary artery disease. Heart 2004; 90: 1211-1213. (Pubitemid 39279914)
21. Pape LA, Tsai TT, Isselbacher EM, Oh JK, O'Gara PT, Evangelista A, et al. Aortic Diameter >or =5.5 cm is not a good predictor of Type A aortic dissection: Observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation 2007; 116: 1120-1127. (Pubitemid 47360214)
22. Suzuki T, Muto S, Miyamoto S, Aizawa K, Horikoshi M, Nagai R. Functional interaction of the DNA-binding transcription factor Sp1 through its DNA-binding domain with the histone chaperone TAF-I. J Biol Chem 2003; 278: 28758-28764. (Pubitemid 36935784)
23. Miyamoto S, Suzuki T, Muto S, Aizawa K, Kimura A, Mizuno Y, et al. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol Cell Biol 2003; 23: 8528-8541. (Pubitemid 37433360)
24. Matsumura T, Suzuki T, Aizawa K, Munemasa Y, Muto S, Horikoshi M, et al. The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Krüppel-like factor 5 through direct interaction. J Biol Chem 2005; 280: 12123-12129. (Pubitemid 40491022)
25. Suzuki T, Aizawa K, Matsumura T, Nagai R. Vascular implications of the Krüppel-like family of transcription factors. Arterioscler Thromb Vasc Biol 2005; 25: 1135-1141. (Pubitemid 40776599)
26. Suzuki T, Matsumura T, Nagai R. Transcriptional regulation at the chromatin level in the cardiovasculature through protein-protein interactions and chemical modifications. Trends Cardiovasc Med 2005; 15: 125-129. (Pubitemid 41138875)
27. Kada N, Suzuki T, Aizawa K, Munemasa Y, Matsumura T, Sawaki D, et al. Acyclic retinoid inhibits functional interaction of transcription factors Krüppel-like factor 5 and retinoic acid receptor-alpha. FEBS Lett 2008; 582: 1755-1760.
28. Suzuki T, Nagai R. Cardiovascular proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 855: 28-34. (Pubitemid 47077725)
29. Suzuki T, Nagai R. Molecular markers for cardiovascular disease: Cardiovascular biomarkers to proteomic discovery. Nat Clin Pract Cardiovasc Med 2008; 5: 295.